Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

What you need to know about the coronavirus right now

Published 06/04/2021, 03:30 pm
Updated 08/04/2021, 03:12 pm

April 8 (Reuters) - Here's what you need to know about the coronavirus right now:

NZ temporarily suspends entry to travellers from India

New Zealand on Thursday temporarily suspended entry for all travellers from India, including its own citizens, for about two weeks following a high number of positive coronavirus cases arriving from the South Asian country.

The move comes after New Zealand recorded 23 new positive coronavirus cases at its border on Thursday, of which 17 were from India. The suspension will start from 1600 local time on April 11 and will be in place until April 28. rollout to continue in Australia

Australia has no current plans to change the rollout of the AstraZeneca (NASDAQ:AZN) COVID-19 vaccine, Prime Minister Scott Morrison said on Thursday, after Europe's drug regulator found possible links between rare blood clots and the vaccine.

Australian authorities have ordered an urgent inquiry into findings from Europe's drug regulator with Morrison expecting updates later on Thursday from the medicines regulator and the immunisation advisory group. guidance in the EU on AstraZeneca shot

European Union health ministers failed on Wednesday to agree a common guidance on the use of the AstraZeneca COVID-19 vaccine, despite calls for coordination across member states to combat public hesitancy over taking the shot. and Spain recommended on Wednesday that it only be used on those over 60 and Britain that people under 30 should get an alternative, due to possible links between the vaccine and very rare cases of blood clots. approved by EU, Germany wants to buy Sputnik vaccine

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Germany is about to start bilateral negotiations with Russia to obtain its Sputnik V COVID-19 vaccine, a source told Reuters on Wednesday, adding that any final agreement depended on Russia providing key data to the European Medicines Agency (EMA). In the preliminary talks, Germany first wants to determine which quantities Russia can deliver and when, the source said.

In any case, Germany will only buy the Russian vaccine once it has been approved by EMA and for this it is paramount that Russia provides the necessary data, the source added. detecting UK variant, Thailand braces for infections

Thailand has detected at least 24 cases of the coronavirus variant B.1.1.7 first identified in Britain, a government health expert said on Wednesday, its first known domestic transmission of the highly contagious variant. The UK variant was found in a cluster of 24 visitors to entertainment venues in Bangkok, which were detected at the weekend. Nearly 200 such venues have been closed for two weeks.

Thai Prime Minister Prayuth Chan-ocha instructed authorities to prepare field hospitals in anticipation of a spike in infections. Ten of his ministers and dozens of lawmakers were self-isolating on Wednesday due to exposure to positive cases.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.